Francis Pollaro

Emerging biopharma companies are critical to the vibrancy of the healthcare landscape, but their long road of drug development fails to translate to successful market launch more often than it does for large pharma. What can be done to improve those odds?

Whether pharma or FDA, healthcare outreach more visible than ever.

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

Bristol Myers Squibb commercial head Chris Boerner believes a straightforward formula is the best formula in advancing innovation and developing talent in today’s complex healthcare climate—an approach he roots in authenticity and “not over engineering,” whether tackling business or culture.

Senior leaders in pharma, healthcare marketing and communications, and advertising got together to discuss the progress and lingering roadblocks in advancing diversity, equity, and inclusion strategies in the life sciences—where the common thread seems clear: the messenger matters.

Pharm Exec catches up with longtime Merck international business leader Kevin Ali to find out how Organon, the ambitious Merck spinoff he formed just over a year ago, has fared so far in delivering on its mission of creating a global leader and difference-maker in women’s health.

What the rising rate of physician-hospital affiliations means for pharma.

How addressing equity gaps can be a boost for brands.

In episode 108, the rest of the PharmExec editorial staff join Elaine and Miranda as they announce and give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders.

The stages of a career well-spent in advancing healthcare innovation.

A storied climb from chemist, to Middle East sales rep, to master of product launch.

Connected TV advertising now a critical component of media mix.

Industry embraces modern approach to commercialization, but keeps human connection at center.

Pharma moves beyond promoting products to increase recognition of company names.

Pandemic lockdowns push pharma into brand-new era of social engagement.

Need for greater transparency and access fuels Big Tech’s presence.

Chief commercial officers gather for an insightful roundtable discussion anchored in the future of sales and marketing in light of new communication media brought on by the pandemic.

It wasn’t long before sales reps realized they needed a new strategy to keep prospect pools flowing—18 months later, a mix of in-person and virtual meetings with healthcare professionals is emerging as the preferred approach moving forward.

New age of drug marketing must consider market access.

The aggressive strategy behind a small company’s quick ascent in migraine market.

Vaccines spotlight recent resurgence of useful messaging tool.